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MODIFIED CONDUIT 
PREPARATION CREATES A 
PSEUDOSINUS IN AN 
AORTIC VALVE-SPARING 
PROCEDURE FOR 
ANEURYSM OF THE 
ASCENDING AORTA 
Mechanical valved conduit replacement of the aortic root is a durable and 
appropriate procedure for many diseases of the ascending aorta, but may sacrifice 
an anatomically salvageable aortic valve. For young active patients and for patients 
with "systemic" arterial disease (atherosclerosis, Marfan's syndrome) who may 
require future operations, life-long anticoagulation with its attendant thromboem- 
bolic versus hemorrhagic risks is not ideal. Several techniques have been suggested 
as aortic valve-sparing options. Recently, a procedure was described that combines 
the freehand homograft techniques with the standard Bentall techniques (David 
procedure). This innovative technique replaces the ascending aorta with a Dacron 
cylinder, spares the aortic valve, and restores competence and thus offers an 
excellent alternative. The durability of this procedure that places the aortic valve 
inside a cylindrical conduit without sinuses of Valsalva is unknown. In selected 
patients, we have used this technique to spare the aortic valve. On the basis of 
experimental data and preliminary computer modeling, with the ope of improving 
the durability, we have modified the conduit o create a "pseudosinus" in our most 
recent nine patients. We have done the David procedure in 10 patients. The 
pseudosinus modification was done in the most recent nine patients. Patients' ages 
ranged from 37 to 71 years (mean 49.9 years). There were five female and five male 
patients. Five patients had Marfan's syndrome and five patients had annuloaortic 
ectasia. There has been no mortality and all patients have had both early and late 
follow-up echocardiography. Five patients have zero to trace aortic insufficiency, 
four patients have trace to mild aortic insufficiency, and one patient has mild or 
"1+" aortic insufficiency. Aortic insufficiency has not progressed in any patient 
during the 18 months of follow-up. The patient with 1+ aortic insufficiency has no 
activity limits, good ventricular function, and no evidence of congestive symptoms. 
One patient who had extensive thoracoabdominal aneurysmal disease has under- 
gone subsequent replacement of the descending aorta to the level of the renal 
arteries and has done well. Aortic valve-sparing replacement ofthe aortic root is an 
excellent procedure for any patient with an ascending aortic aneurysm and an 
anatomically salvageable valve. We believe that by modifying the proximal conduit 
and creating a "pseudosinus" into which the leaflets can retract without contact of 
the cylindrical conduit we may increase the longevity of the native aortic valve in this 
procedure. (J TItORAC CARDIOVASC SURG 1995;109:1049-58) 
Richard P. Cochran, MD, Karyn S. Kunzelman, PhD, A. Craig Eddy, MD, 
Bradley O. Hofer, MD, and Edward D. Verrier, MD, Seattle, Wash. 
A ortic valve insufficiency is increasing as a reason for aortic vane surgery)' 2 Until recently, the 
procedure of choice was replacement of the aortic 
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root with a composite valved conduit and reimplan- 
tation of the native coronary arteries. In 1992 Dr. 
Tirone David described a reconstructive procedure 
in which the native aortic valve is spared and 
resuspended within a tubular conduit during aortic 
root replacement) However, by resuspending the 
aortic valve within a tubular conduit the David 
procedure creates an abnormal environment for the 
valve. How this abnormal reconstruction affects 
long-term valve durability remains a question. To 
improve durability in this reconstructive t chnique, 
we have modified the David procedure. To provide 
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Fig. 1. Measurements u ed for mathematical derivation of increased length from Ca (original circumfer- 
ence of conduit) to C2 (modified circumference of conduit). See text for explanation of variables. 
a more natural environment for the aortic valve, we 
created three "pseudosinuses" in the supravalvular 
region by scalloping the base of the conduit around 
each commissural position. In our initial 10 patients, 
the nine most recent underwent this modified recon- 
struction. This report explains the theoretic basis for 
this modification, presents the cases of our patients 
and their early follow-up, and demonstrates echo- 
cardiographic results in the two techniques. 
Methods 
Theory. The sinuses of Valsalva are crucial for normal 
function of the aortic valve and root, and any aortic 
reconstruction must be done with this fact kept in mind. 
The sinuses, in concert with the sinotubular junction, 
create eddy currents within the supravalvular region that 
initiate valve closure and promote coronary artery blood 
flow. This eddy formation assists in leaflet coaptation and 
ensures early and coordinated closure of all three aortic 
leaflets. The curvilinear configuration created by the 
unique attachment of the aortic leaflets to the sinuses of 
Valsalva allows for load or stress sharing between the 
valve leaflets and aortic wall. Any aortic reconstruction 
that disrupts this load-sharing configuration will result in 
increased stress, increased fatigue, and decreased durabil- 
ity of the valve. 
The creation of pseudosinuses byconduit modification 
is simple. In the originally described procedure, a Dacron 
cylinder (conduit) of "fixed" diameter and circumference 
is matched to a "fixed" anatomic diameter and circumfer- 
ence, that is, the anulus. In our technique, scalloping the 
base of the conduit increased the circumference of the 
cylinder. When this new increased circumference is sewn 
to the "fixed" anatomic anulus, the cylindrical shape of 
the conduit is modified. The goal was to guide this 
reshaping so that the conduit would bulge outward at 
three locations and create pseudosinuses. These pseudo- 
sinuses would allow the aortic valve leaflets to open 
without abutting the conduit wall and theoretically would 
recreate the configuration necessary for the load sharing 
between leaflets and conduit similar to that of the native 
aortic root configuration. 
Before clinical application of this technique, mathemat- 
ical support for this concept was derived. Fig. i illustrates 
the appearance of the modified free edge of conduit as if 
the conduit had been cut along its long axis and laid out 
flat. Ce indicates the circumference of the unmodified 
conduit, and C 2 is the new free edge length of the 
modified conduit. If the valve is considered to be symmet- 
ric, the relationship between C1 and C2 can be based on 
the height of the scallops that are cut into the graft. For 
the purpose of mathematical nalysis, it is assumed that 
both the upper and lower curvatures of the scallop are 
arcs of a circle. The length of each of these arcs (3 upper 
and 3 lower arcs) can be determined simply on the basis of 
the known diameter of the graft and the chosen scallop 
height. 
For each upper and lower scallop, the arc length, s, is 
defined by the formula 
s = RO (1) 
where R is the radius of circular arc (in millimeters) and 
0 is the angle (radians). R and 0 are not directly known; 
however, they can be calculated from the chord length c 1 
and arc height h 1. The trigonometric formula 4that defines 
the relationship is
cl = \/4hff2R - hi) (2) 
Solving for R gives 
Cl 2 + 4hl  2 
R = (3) 
8hl 
Next, the trigonometric formula defining the angle 0 is 
Cl 
0 = 2sin - I  - -  (4) 
2R 
Substituting equation 3 into equation 4 gives 
4hlCl 
0 = 2sin -1 - -  (5) 
q2 + 4h12 
Substituting equations 3 and 5 into equation 1 gives the 
arc length based only on chord length and height: 
Cl 2 q- 4hl 2 4hlCl 
s - 4hl sin-1 (6) Cl 2 + 4hl  2 
Finally, knowing that ca is equivalent to 1/~ of the original 
circumference (C1, which can be calculated from the 
diameter [D]), and knowing that h a is 1/2 of the scallop 
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Fig. 2. Graphic representation f increase in free edge length (modified circumference) for various callop 
heights for several conduit sizes. 
height (H), the final equation for the new free edge length 
(C2) of the modified conduit is 6 times the arc length s, or 
(~-D) 2 + 36H 2 12~rDH 
C 2 = 6s - 12H sin -1 (7rD)2 + 36H2 (7) 
The relationship between scallop height and resultant 
modified free edge length is shown for varying graft 
diameters in Fig. 2. It can be seen that a significant 
increase in free edge length can be achieved by scalloping 
the graft. 
Fig. 3 shows the idealized geometric result if this new 
free edge length (C2) is attached to the original annular 
circumference (C1) in the same horizontal plane and with 
symmetric fixation of the three commissural posts. The 
physical result is that the extra material in the scallops will 
be forced to bulge upward and outward creating pseudo- 
sinuses. 
In addition to creating pseudosinuses, we wanted to 
know the amount of bulging that could be created, so the 
maximum degree of bulging or "additional sinus depth" 
was also calculated by trigonometric relationships. In Fig. 
3, the numeric value of the additional sinus depth is h3 - 
h 2. Once again assuming circular arcs, the relationship 
between chord length (c), chord height (h), and arc length 
(s) defined in equation 6holds true. In this case the chord 
length c2 is constant (and can be calculated from diame- 
ter). The two arc lengths of interest are equivalent to 1/3 of 
C 1 and C2, respectively. The values for h 2 and h 3 can then 
be solved implicitly from equation 6. 
The relationship between scallop height and resultant 
additional sinus depth is shown for varying raft diameters 
in Fig. 4. It can be seen that a definable increase in sinus 
depth can be gained by scalloping the graft. 
Patients and technique. Between June 1992 and Au- 
gust 1993, we performed 10 aortic valve-sparing opera- 
tions for primary aortic root pathologic onditions, using 
the modified technique in the most recent nine patients. 
For the modified technique, the conduit was trimmed to 
create three symmetric scallops in the "annular" end of 
C2 
Fig. 3. Idealized geometric onfiguration attained with 
new free edge length (C2) attached to annular circumfer- 
ence (C1) and commissural posts and additional sinus 
depth that results (h3 - h2). See text for explanation of 
variables. 
the Dacron conduit, with each scallop having a maximal 
height of 5 to 7 mm depending on conduit size (Fig. 5). 
Other than the difference in trimming of the base of the 
conduit, the technique of insertion is similar to the 
technique described by David with symmetric, subvalvular 
stitches along the proximal conduit, resuspension of the 
valve within the conduit, and reimplantation of the coro- 
nary arteries (Fig. 6). 
In our series, there were five female and five male 
patients. The underlying pathologic conditions were 
equally divided between documented Marfan's disease (5 
patients) and annuloaortic ectasia (5 patients). The pa- 
tients' ages ranged from 37 to 71 years with an average age 
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Fig. 4. Graphic representation f relationship between scallop height and resultant additional sinus depth 
shown for several conduit sizes. 
Fig. 5. Creation of three symmetric scallops in proximal 
conduit and circumferential subvalvular stitch placement. 
Fig. 6. Completed conduit placement and valve resus- 
pension with creation of pseudosinuses. 
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of 49.9 years. Two patients had bicuspid aortic valves. 
Both had distinct commissural posts and relatively normal 
alignment in relation to the coronary ostia. In each 
circumstance, the patient's trong desire to avoid anticoagu- 
lation therapy was an additional motivating consideration. 
The decision as to which patients are appropriate 
candidates for this operation is multifactorial. The pa- 
tients selected tended to be younger, but any patient with 
aneurysmal disease of the ascending aorta and an anatom- 
ically functional and salvageable valve was considered a
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Table I. Patient data summary 
Age Marfan's Crossclamp CPB time 
Patient (yr) syndrome Additional procedures time (rain) (rain) Complications A1 
1 55 + CABG× 2 168 226 
2 37 + CABG× 1, IABP, RVAD 113 329 
3 47 - None 148 183 
4 56 + None 165 216 
5 55 - CABG× 2 148 183 
6 42 - None 139 174 
7 43 - None 170 196 
8 46 + None 140 158 
9 71 - TAA replacement 171, DHCA = 15 249 
10 47 + None 127 161  
None TR-M 
RVAD 0-TR 
None 0-TR 
Amaurosis fugax, parox- 0-TR 
ysmal atrial fibrillation 
Bilateral pleural effusion TR-M 
None TR-M 
None 0-TR 
Pacemaker and atrial TR-M 
fibrillation 
None 0-TR 
None Mild (1 +) 
CPB, Cardiopulmonary b pass; AI, aortic insufficiency; CABG, coronary artery bypass grafting; TR, trace; M, mild; IABP, intraaortic balloon pump; RVAD, 
right ventricular assist device; TAA, transverse arch aneurysm; DHCA, deep hypotbermic circulatory arrest. 
candidate for this procedure. The only outlier in our 
group was the 71-year-old man. His case was unique in 
that he had a combined ascending aortic aneurysm with 
aortic insufficiency and a transverse arch aneurysm and, in 
addition, he had a large thoracoabdominal aneurysm that 
would necessitate later surgical intervention. This com- 
plex anatomy that dictated multiple surgical procedures 
was a clear indication for valve sparing for the benefit of 
avoiding anticoagulation in this patient. 
It was difficult o determine before operation whether 
the patients' anatomy made them good candidates for this 
procedure. Despite having preoperative chocardio- 
graphic data, the valvular anatomy could not always be 
defined. In one patient early in the series, bicuspid 
anatomy was first identified intraoperatively. This patient 
was reluctant o consider anticoagulation because of 
life-style choice. Intraoperative assessment showed that 
the valve was pliable, only one commissure was fused, and 
commissural post alignment was nearly normal. As a 
result of these findings, even though the valve was bicus- 
pid, we spared the valve. The resuspension of this valve 
and its postoperative function were quite acceptable. 
After that experience, we have continued to spare selected 
bicuspid valves. If the bicuspid valve is pliable, noncalci- 
fled, and has near normal commissural post alignment so 
that resuspension can be accomplished, we will consider a 
valve-sparing procedure. 
Results 
Our results with this valve-sparing procedure for 
aortic aneurysmal disease have been excellent, with 
no mortality and minimal morbidity (Table I). One 
patient required right ventricular assistance because 
of inadequate retrograde myocardial protection but 
did well. The operation is technically challenging 
with an average aortic crossclamp time of 145.9 
minutes and an average cardiopulmonary bypass 
time of 209.6 minutes. Additional procedures were 
done in four patients, with three having concomitant 
coronary artery bypass grafting and one having 
repair of transverse arch aneurysm with the use of 
deep hypothermic circulatory arrest. 
Patient follow-up ranged from 4 to 20 months, 
with a mean follow-up of 13.3 months. New York 
Heart Association functional class status was most 
recently assessed by phone contact with either the 
patient, the immediate family, or the physician 
primarily caring for the patient. All patients are 
active and in New York Heart Association func- 
tional class I or II, by the follow-up telephone 
contact. All patients have undergone follow-up 
echocardiograms early (within the initial hospital- 
ization) and late (from 3 to 6 months after opera- 
tion). Early and late echocardiographic findings 
have remained stable without progression of any 
residual valve insufficiency. Five patients have zero 
to trace aortic insufficiency, four patients have trace 
to mild (1+) aortic insufficiency, and one patient has 
mild (1 +) aortic insufficiency. Both bicuspid valves 
showed trace to mild AI at the time of the procedure 
and have remained so. Six weeks after receiving the 
modified David procedure, the 71-year-old patient 
underwent an uneventful thoracoabdominal re- 
placement of the aorta. 
The creation of pseudosinuses was confirmed 
both intraoperatively b visual inspection and post- 
operatively by echocardiography. Fig. 7, A, shows 
the echocardiogram in short axis of the first patient 
in our series, who received the originally described 
David procedure. There is no sinus formation seen. 
In contrast, Fig. 7, B, is the short-axis view of the 
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Fig. 7. A, Short-axis echocardiogram from first patient (without modified conduit) demonstrates no sinus 
formation. B, Short-axis view from patient with modified conduit demonstrates three pseudosinuses 
depicted by three arrows. C, Long-axis view from first patient (without modified conduit) demonstrates 
linear attachment of conduit to anulus and no sinus formation. D, Long-axis view of patient with modified 
conduit demonstrates curvilinear attachment of onduito anulus, pseudosinus formation marked by three 
straight arrows, and aortic leaflet retracting into "sinus" space shown by curved arrow. 
echocardiogram of a patient in whom we used the 
modified technique. The constructed pseudosinuses 
are apparent. In the long-axis view, in the first 
patient in whom there was no modification to the 
conduit, there is no evidence of bulging or sinus 
formation (Fig. 7, C). The similar view for the 
patient with scalloping of the conduit in the modi- 
fied technique shows not only that a pseudosinus is 
present, but also that the leaflets retract without 
contact o the conduit walls (Fig. 7, D). 
Postoperative complications have b en accept- 
able. Persistent bilateral pleural effusions that re- 
quired drainage and sclerosis developed in one 
patient. The effusions arc now well controlled. This 
patient has stable trace to mild aortic insufficiency 
on multiple echocardiographic evaluations and has 
no evidence of ventricular failure as a cause of 
the effusions. Another patient had an episode of 
amaurosis fugax several months after hospital 
discharge. The patient underwent valuation in- 
cluding negative carotid duplex and ophthalmologic 
examinations that did not show retinal changes. 
She was found by Holter monitoring to have in- 
termittent episodes of atrial fibrillation and flutter. 
She was not receiving antiplatelet oranticoagulation 
therapy during these episodes. She has begun to 
receive low-dose warfarin (Coumadin) therapy for 
this. Refractory atrial arrhythmias developed in 
one other patient that necessitated a pacemaker 
placement 10 months after operation andthis pa- 
tient has also been placed on low-dose warfarin 
therapy. 
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Discussion 
The increasing prevalence of aortic insufficiency is
multifactorial and recently the traditional manage- 
ment has been being scrutinized. Aortic valve insuf- 
ficiency is caused not only by abnormalities of the 
valve leaflets (endocarditis, rheumatic heart disease, 
congenital fusion) but also by abnormalities of the 
aortic root and anulus that support the valve. The 
prevalence of both annular dilation alone or aortic 
root aneurysm with concomitant annular dilation 
appears to be increasing. 1' 2 Composite valved con- 
duit replacement of the aortic root with reimplan- 
tation of the native coronary arteries has provided 
an excellent solution for most patients. 5-7 The com- 
posite valved conduit, however, does obligate the 
patient o the risks of thromboembolism or antico- 
agulation therapy, or both, if a mechanical valve is 
incorporated. The estimated thromboembolic rate 
with mechanical valves is 1% to 2% per patient-year 
and there is a separate but equal risk of bleeding 
complications. 8-14 In those circumstances in which 
biologic valves are used in conjunction with a con- 
duit, there is a proven limited durability. Thus with 
either choice, mechanical or biologic valve, the risks 
are not small. Because annuloaortic ectasia often 
presents in the younger, more active patient popu- 
lation, the anticoagulation risks are frequently more 
unacceptable and lead to potential delays in surgical 
intervention until ventricular performance deterio- 
rates. In the patients with systemic aneurysmal 
vascular disease (for example, Marfan's syndrome, 
connective tissue disorders) the natural history of 
the disease often includes multiple surgical proce- 
dures, as In these patients, a mechanical aortic pros- 
thesis with obligatory anticoagulation i creases the 
risks of perioperative complications during subse- 
quent operative interventions. 
In 1992 Dr. Tirone David described analternative 
procedure in which the native aortic valve is spared 
during aortic root replacement) The David proce- 
dure excises all aneurysmal aortic tissue from the 
aortic arch proximally and extends this excision to 
the level of the aortic anulus, sparing only a small 
rim of tissue adjacent to he commissural posts, thus 
avoiding future aneurysm formation. To facilitate 
positioning of the graft, that portion of the conduit 
adjacent o the commissural post is scalloped be- 
tween the right and left coronary sinuses. Once the 
conduit is secured at the level of the aortic anulus, 
the aortic valve is resuspended inside the Dacron 
conduit by a technique similar to free-hand ho- 
mograft implantation. Standard reimplantation of 
Forward 
Blood Flow 
I 
/ Sinus Ridge 
Flow 
Eddies 
Fig. 8. Schematic representation of aortic valve and root 
demonstrating role f sinus ridge in creation f eddy 
currents for enhanced valve closure and coronary artery 
perfusion. 
the coronary arteries in their appropriate positions 
and distal reconstruction of the aortic arch with the 
conduit completes the procedure. 3'16 Unfortu- 
nately, although this procedure spares the native 
aortic valve, the valve is resuspended in a cylinder 
and that is an unnatural environment for the valve. 
The resuspension of the valve in a cylinder ig- 
nores the fact that he aortic valve and the aortic: 
root are inseparable in their physiologic roles. The: 
relationship of the aortic valve to the aortic root is; 
one of natural synergy. Part of this synergy is the, 
configuration of the valve, the sinuses, and the: 
sinotubular junction. The aortic valve, the sinuses of 
Valsalva, the coronary ostia, and the sinotubular 
ridge are positioned and configured to facilitate 
valve closure, to encourage coronary tery blood 
flow, and to share stress and load bearing) 7-19 This 
configuration is necessary to create eddy formation 
in the blood flow within the aorta. It is this eddy 
formation that initiates valve closure and promotes 
coronary artery perfusion (Fig. 8). The sharing of 
the stress and load bearing between the leaflets and 
root is an equally crucial part of the interaction of 
this system. 2° Unfortunately, as in any interdepen- 
dent system, dysfunction of one component ulti- 
mately results in disruption of the other parts of the 
system. This interdependence of the aortic valve and 
root explains both aortic valvular dysfunction caused 
by a disease process that only involves the aortic 
root and the potential for early failure in any 
reconstructive t chnique that ignores it. Because all 
aortic valve-sparing procedures are based on the 
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three premises that the underlying disease arises 
from the aortic root or wall tissue, that the aortic 
valve dysfunction is all caused by the disease of the 
root, and that the valve should thus be saved, this 
same logic dictates that the aortic valve should be 
resuspended in as natural an environment as possi- 
ble to attain normal function and durability. 
The procedure as done by David suspended the 
aortic valve within a cylindrical conduit and thus 
creates an abnormal environment for the valve. 
Theoretically, several questions of durability arise. 
The most prominent question is the effect on the 
ability of the valve to manage stress and load 
bearing after resuspension i a cylindrical conduit 
without sinuses of Valsalva and without a sinotubu- 
lar junction. How this abnormal reconstruction af- 
fects long-term valve durability remains a question 
for theoretic debate and laboratory investigation, 
However, the possible benefits of sparing a "nor- 
mal" valve and avoiding anticoagulation are too 
compelling not to offer this type of procedure to 
selected patients. In initiating our experience, this 
question of suspending the valve in a cylindrical 
conduit remained. During the first procedure, after 
scalloping of the conduit as done by David, we 
observed an asymmetry to the conduit. Once the 
annular stitches were secured, the scalloped region 
of the conduit bulged outward. This bulging on 
either side of the commissural post appeared similar 
to half of a sinus of Valsalva. As a result of this 
observation, we discussed the theoretic possibility of 
creation of a pseudosinus by scalloping of the base 
of the conduit at all three commissural positions. 
The theoretic basis for creation of three pseudosi- 
nuses proved valid as outlined earlier, thus we have 
modified our technique to achieve this in the re- 
maining nine patients reported on in this series. 
Our initial experience with this technique has 
confirmed our belief that the sinuses of Valsalva are 
a crucial component of the aortic root. The normal 
aortic valve relies on their presence for initiation of 
valve closure and enhancement of coronary artery 
flow. The leaflets and the sinuses also work in 
concert for load sharing and thus reduce the stress 
of both the leaflets and the aortic wall. The creation 
of pseudosinuses in the conduit is an attempt o 
recreate this natural anatomic arrangement. This 
modified technique is reproducible, asily done, and 
potentially more durable than the procedure as it 
was originally described. 
In conclusion, the sparing of the aortic valve in 
selected cases of aortic insufficiency is an excellent 
alternative to procedures that require mechanical 
valve replacement. The long-term durability of the 
aortic valve in a cylindrical conduit without sinuses 
of Valsalva is questionable because of the alter- 
ations in stress on the valve leaflets, fluid flow 
dynamics, and interaction between the leaflets and 
the aortic wall. A simple modification of the conduit 
allows for creation of pseudosinuses within the 
conduit. We believe, for patients with aortic root 
aneurysms and relatively normal aortic valves, that 
this modified aortic valve-sparing aortic root re- 
placement is the procedure of choice. 
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Discuss ion 
Dr. D. Craig Miller (Stanford, Calif.). This is a beautiful 
concept and wonderful theory. It builds on the solid 
physiologic oncepts developed by Stan Nolan and his 
colleagues at the University of Virginia that the aortic 
root--the sinuses, the sinotubular idge, and the leaf- 
lets--are one functional dynamic unit. I think all of us 
were impressed by the elegant mathematical modeling 
that was done by Karyn Kunzelman. 
We also have a small number of patients in whom we 
have used the Yacoub, David, or Griepp procedure (these 
three physicians came up with similar ideas, starting with 
Sir Magdi Yacoub in 1975). We have always carefully 
excluded those patients with the Marfan syndrome, how- 
ever, and I would like to go into that a bit. This operation 
basically is an orthotopic aortic valve autograft with 
Dacron cylinder eplacement of the aortic root, including 
all of the sinuses, and coronary artery reimplantation. 
First, I think we have to be careful because none of us 
knows if this is the right way to go, and we will not know 
with certainty for many years. To wit, Randall Griepp and 
his colleagues at Mt. Sinai Hospital in New York have 
already abandoned this type of procedure because the 
durability of the aortic valve repair was not satisfactory. 
Tirone David himself has told me that he will not do this 
procedure any longer in patients with the Marfan syn- 
drome who have a large aortic anulus because he is afraid 
of limited valve durability in these specific patients. Hans 
Borst in Hannover, Germany, however, has relied only on 
this type of procedure since November 1993 and is no 
longer using mechanical composite valve grafts. 
I am sure most of you know that the gene responsible 
for the Marfan syndrome has been mapped with the use of 
genetic linkage studies to the long arm of the fifteenth 
chromosome; this locus was subsequently found to be the 
fibrillin-1 gene. Fibrillin is a large glycoprotein structural 
component of the microfibrils of the connective tissue 
matrix and can be identified by monoclonal antibody 
techniques in cultured skin and aortic fibroblasts. The 
disease is not quite that simple, that is, just involving a 
mutant or abnormal fibrillin-1 gene, because there are 
missense mutations, nonsense mutations, frame replica- 
tion errors, and premature xon termination errors. Thus 
the disease is pretty complex. This results in not just 
normal or abnormal fibrillin, but there may also be various 
patterns of fibrillin synthesis or deposition abnormalities. 
Uta Francke and Heinz Furthmayer at Stanford are 
examining the aortic valve leaflets from patients with the 
Marfan syndrome to see whether they can identify the 
absence of fibrillin-1 or abnormal fibrillin synthesis or 
deposition. If so, do you think it is really wise to save these 
valves in patients with the Marfan syndrome? 
Dr. Coehran. Marfan's syndrome is a concern to all of 
us involved in this, but we liken the situation to mitral 
valve repair and diseased tissue. We do not know what the 
long-term durability is and we are just trying to return the 
tissue to a normal physiologic environment and see what 
the long-term durability is, as we do with the mitral valve. 
We hope that, whatever the disease process in the tissue, 
the disease will not progress if the valve is in a normal 
physiologic state. We have to follow up these patients 
closely and disease progression is a concern, but we are 
obviously being fairly aggressive with the Marfan popula- 
tion. 
Dr. Miller. With regard to your rationale, you state that 
anticoagulation therapy in young patients (if a mechanical 
composite valve graft is used) carries an increased risk of 
anticoagulation-related bleeding complications. I am not 
sure I agree with that. I think anticoagulation is most 
difficult in elderly patients and that they have the highest 
risk over time of bleeding. 
Dr. Cochran. Right. We have only one patient who 
would qualify as elderly and his was a special situation: 
this patient needed multiple procedures and the ascend- 
ing aorta replacement was the first to be done. He had a 
thoracoabdominal ortic replacement that was done 
within 6 weeks after this procedure, and he really did not 
want to be taking anticoagulation medications. This pa- 
tient is probably in an exceptional group and he skews our 
age numbers, For the most part we have selected carefully 
a young population who are relatively adamant about not 
receiving anticoagulation therapy. Without our 71-year- 
old patient, our age mean drops to near 40 years. 
Dr. Miller. It is the patient'S desire to avoid anticoag- 
ulation therapy, then? You are not really saying that 
young patients have more bleeding complications when 
they are receiving warfarin? 
Dr. Cochran. Correct. 
Dr. Miller. You also state that you would like to avoid 
warfarin anticoagulation in these young patients, particu- 
larly those with the Marfan syndrome, because they are 
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potentially going to need other operations in the future. I
think all of us know these patients do unfortunately need 
all too many operations eventually. Therefore, I would 
caution use of this procedure in patients with the Marfan 
syndrome because I think we should do everything we can 
to make the initial procedure more "curative," or at least 
a more durable and definitive one. Could you comment? 
Dr. Cochran. That is a difficult clinical question to 
answer, but there is not a great answer in this patient 
population right now. We have taken the tack that if the 
patient desires to avoid anticoagulation therapy, we think 
this is a good alternative operation. We do inform them 
there is the possibility in a relatively short time, because 
we do not have follow-up, that they may have to undergo 
aortic valve replacement. The patients are made aware of 
that and we make the decision with them in that regard. 
Dr. Miller. You have already mentioned that one 
71-year-old patient skewed your age numbers, which 
ranged from 37 to 71 years, with an average age of 50. I 
note that there were no children or adolescents in your 
series in whom this procedure might indeed have much 
greater theoretic appeal. 
Dr. Cochran. Yes. We have been somewhat biased by 
Dr. David's experience. At last count, he has done his 
operation in more than 40 patients and he has only one 
patient, a 14 year old, who has progressed as far as aortic 
insufficiency. We have actually avoided these patients in 
their teenage years. We would extend the age to the 
younger adults, in their twenties or so, but we have 
avoided patients who are still growing or in whom the 
disease process is not defined. 
Dr. Miller. The average aortic crossclamp time was just 
shy of 21/2 hours and average pump time was 31/2 hours. 
How do you justify these long times? I agree with you that 
this procedure takes a lot longer than insertion of a simple 
mechanical composite valve graft. In which specific pa- 
tients would the long ischemic times not be acceptable? 
Dr. Cochran. We have to be selective. Again, we choose 
patients who have good ventricular function and who Can 
tolerate the extended procedure. There is no question it is 
a much bigger operation, particularly if combined with 
other procedures, uch as coronary artery bypass grafting. 
Dr. Miller. This question is theoretic also. You might 
want to refer it to Karyn Kunzelman. By excising these 
scallops in the graft, you must be distributing more 
stresses to other regions in the proximal suture line. 
Because the proximal sutures come from the left ventric- 
ular outflow tract through the myocardium to the outside, 
could excessive stresses there perhaps portend a higher 
likelihood of late disruption or recurrent aortic regurgita- 
tion in the future? 
Dr. Cochran. I do not think that we have evidence that 
there is more stress there. There is an increased circum- 
ference but it is reduced to the original Ca size, because 
we use the same annular stitches. If you are thinking that 
there is a radial type of expansion of the anulus, other 
than physiologic, I do not think that exists because we use 
the same numbers as if we put a conduit there. Dr. 
Kunzelman might address more specifics as far as the 
tissue stresses at that level, but we have not done that per 
se.  
Dr. Kunzelman. I do not think we can answer that 
question definitively at this point. I would not predict hat 
there are higher stresses because of the way the conduit is 
being reconfigured to the natural sinuses, but we are 
addressing this in a computer model so we will be able to 
answer this question in the future. 
Dr. Miller. Your finite element analyses should prove to 
be illuminating. We look forward to an answer. 
Finally, at least in theory, I think all of us find intuitively 
attractive this concept hat the three pseudosinuses will 
increase the durability of the aortic valve repair, but, as 
you mentioned, your follow-up is short and you are being 
cautious. Are you going to test your hypothesis rigorously 
in a prospective randomized trial? 
Dr. Coehran. That is the ultimate test in any procedure 
like this. It is difficult o randomize this patient population 
because we do not know what population to randomize 
them against. We would have a whole other group of 
complications in using the Bentall or valved-conduit pro- 
cedure. I am not sure they would truly be the same patient 
population in a randomized sense, but we are discussing 
that. Right now we are fairly committed to this operation 
in this patient population and have not embarked on 
randomization. 
iDr. Miller. I am not sure I agree with this logic for not 
randomizing the patients. 
Dr. Cochran. In other words, one patient will face the 
risk of anticoagulation, and the durability of the natural 
valve, which is the test in the operation, would not be 
compared. 
Dr. Miller. I am sorry, I did not state the hypothesis 
clearly enough. I was thinking of comparing the regular 
Yacoub, David, or Griepp operation (without he pseudo- 
sinuses) with your procedure incorporating the three 
pseudosinuses. 
Dr. Cochran. Well, because David has already modified 
his operation to try to attain a similar bowing, although is 
technique is a little different from ours, I do not think 
anybody really wants to stay with a cylindrical conduit. For 
this reason, at present we are not randomizing. 
